1.88 (-3.54%)
As of May 03, 2023
Source:
Jounce Therapeutics, Inc is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. Our strategy is to use a biomarker-driven approach from discovery through clinical development.
| Country | United States |
| Headquarters | cambridge, massachusetts |
| Phone Number | 857-259-3840 |
| Industry | manufacturing |
| CEO | Richard Murray |
| Website | www.jouncetx.com |